540 related articles for article (PubMed ID: 24029937)
1. Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis.
Honardoust D; Kwan P; Momtazi M; Ding J; Tredget EE
Methods Mol Biol; 2013; 1037():203-31. PubMed ID: 24029937
[TBL] [Abstract][Full Text] [Related]
2. Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring.
Honardoust D; Varkey M; Marcoux Y; Shankowsky HA; Tredget EE
J Burn Care Res; 2012; 33(2):218-27. PubMed ID: 22079916
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo.
Ding J; Ma Z; Liu H; Kwan P; Iwashina T; Shankowsky HA; Wong D; Tredget EE
Wound Repair Regen; 2014; 22(5):622-30. PubMed ID: 25139227
[TBL] [Abstract][Full Text] [Related]
4. Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring.
Honardoust D; Ding J; Varkey M; Shankowsky HA; Tredget EE
J Burn Care Res; 2012; 33(5):668-77. PubMed ID: 22210076
[TBL] [Abstract][Full Text] [Related]
5. Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar.
Honardoust D; Varkey M; Hori K; Ding J; Shankowsky HA; Tredget EE
Wound Repair Regen; 2011; 19(3):368-78. PubMed ID: 21518082
[TBL] [Abstract][Full Text] [Related]
6. Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes.
Varkey M; Ding J; Tredget EE
Tissue Eng Part A; 2014 Feb; 20(3-4):716-27. PubMed ID: 24090416
[TBL] [Abstract][Full Text] [Related]
7. Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar.
Varkey M; Ding J; Tredget EE
Biomaterials; 2011 Oct; 32(30):7581-91. PubMed ID: 21802722
[TBL] [Abstract][Full Text] [Related]
8. The effects of TGF-β1 and IFN-α2b on decorin, decorin isoforms and type I collagen in hypertrophic scar dermal fibroblasts.
Eremenko EE; Kwan PO; Ding J; Ghosh S; Tredget EE
Wound Repair Regen; 2024; 32(2):135-145. PubMed ID: 38243615
[TBL] [Abstract][Full Text] [Related]
9. Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells.
Ding J; Ma Z; Shankowsky HA; Medina A; Tredget EE
Wound Repair Regen; 2013; 21(3):448-55. PubMed ID: 23627585
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar.
Kwan P; Ding J; Tredget EE
PLoS One; 2015; 10(4):e0123054. PubMed ID: 25837671
[TBL] [Abstract][Full Text] [Related]
11. The natural behavior of mononuclear phagocytes in HTS formation.
Zhu Z; Ding J; Ma Z; Iwashina T; Tredget EE
Wound Repair Regen; 2016; 24(1):14-25. PubMed ID: 26519112
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
[TBL] [Abstract][Full Text] [Related]
13. A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar.
Momtazi M; Kwan P; Ding J; Anderson CC; Honardoust D; Goekjian S; Tredget EE
Wound Repair Regen; 2013; 21(1):77-87. PubMed ID: 23126488
[TBL] [Abstract][Full Text] [Related]
14. Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring.
Shi JH; Guan H; Shi S; Cai WX; Bai XZ; Hu XL; Fang XB; Liu JQ; Tao K; Zhu XX; Tang CW; Hu DH
Arch Dermatol Res; 2013 May; 305(4):341-52. PubMed ID: 23321694
[TBL] [Abstract][Full Text] [Related]
15. Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process.
Wang J; Ding J; Jiao H; Honardoust D; Momtazi M; Shankowsky HA; Tredget EE
Wound Repair Regen; 2011; 19(2):274-85. PubMed ID: 21362096
[TBL] [Abstract][Full Text] [Related]
16. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
Ferguson MW; O'Kane S
Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
[TBL] [Abstract][Full Text] [Related]
17. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars.
Bellemare J; Roberge CJ; Bergeron D; Lopez-Vallé CA; Roy M; Moulin VJ
J Pathol; 2005 May; 206(1):1-8. PubMed ID: 15772942
[TBL] [Abstract][Full Text] [Related]
18. Dermis, acellular dermal matrix, and fibroblasts from different layers of pig skin exhibit different profibrotic characteristics: evidence from in vivo study.
Zuo Y; Lu S
Oncotarget; 2017 Apr; 8(14):23613-23627. PubMed ID: 28423561
[TBL] [Abstract][Full Text] [Related]
19. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
20. Deep dermal fibroblasts contribute to hypertrophic scarring.
Wang J; Dodd C; Shankowsky HA; Scott PG; Tredget EE;
Lab Invest; 2008 Dec; 88(12):1278-90. PubMed ID: 18955978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
